Table 1

Clinicopathological data of HCCa patients

CaseAge/GenderStageGradeGC/AT polymorphismLOH
161/MIIIA2GCn.i.
265/MII1GCn.i.
379/MII1GCn.i.
463/FIIIA2GCn.i.
564/MIVA2GC/AT
660/MII2GC/AT
765/MII1GC/AT
870/MIIIA1GC/AT
950/FII3GCn.i.
1055/MI2GCn.i.
  • a HCC, hepatocellular carcinoma; LOH, loss of heterozygosity; M, male; F, female; n.i., not informative; –, no LOH.